Market Access Specialty Pharmacy Accreditation: DCI’s Exclusive Analysis Reveals a Market at an Inflection Point Drug ChannelsThe Drug Channels Institute (DCI) team attended Asembia's AXS26 Summit last week.Read full story pharminent May 5, 2026 (Last updated: May 5, 2026) Drug Channels The Drug Channels Institute (DCI) team attended Asembia’s AXS26 Summit last week. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Lannett, Lanexa Biologics and Sunshine Lake secure FDA approval for LanglaraNext: Cytokinetics heart drug scores in closely watched trial Related Stories Market Access pharminent June 12, 2026 Market Access Aquipta recommended by NICE for acute migraine treatment pharminent June 10, 2026 Market Access AbbVie’s migraine drug cleared for migraine attacks on NHS pharminent June 10, 2026
